Group One Trading’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Group One Trading's NRIX Position: Q3 2026 in Review
Group One Trading increased its Nurix Therapeutics (NRIX) stake by 36% in Q3 2026, buying an estimated $2.44K and bringing the position to 370 shares worth $8.77K. The position accounts for ﹤0.01% of the portfolio, ranked #6397.
Group One Trading first reported a position in NRIX in Q3 2021 and has held it in 8 quarters since. The position peaked at $45.5K in Q2 2024. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Group One Trading held 370 shares of Nurix Therapeutics worth $8.77K as of Q3 2026.
- Group One Trading bought 98 Nurix Therapeutics shares in Q3 2026, an estimated $2.44K.
- Nurix Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6397 holding.
- Group One Trading first reported a position in Nurix Therapeutics in Q3 2021 and has held it in 8 quarters since.
- Group One Trading's Nurix Therapeutics position peaked at $45.5K in Q2 2024.
- 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.